They have threatened to boycott undergraduates at Oriel College unless it removes a sculpture of its imperialist benefactor from the building’s façade...

 The vaccine is cheaper and easier to store than the two already approved from Pfizer and Moderna...

The group that received a lower dose better protected than those getting full shots...

Health minister Harsh Vardhan had earlier this year announced a plan to vaccinate around 250 million people with 500 million doses of the vaccine by July 2021...

Vaccine produces strong immune response in older adults ...

The first results from the clinical trials on the Moderna and Pfizer-BioNTech products have shown more than 90 per cent efficacy and bolstered hopes for early global rollouts...

 The vaccine also triggers lower adverse responses among the elderly...

The country is already assessing three other vaccine candidates — two homegrown and one developed by Oxford researchers...

Cipla head confirms this is the same that the Serum Institute of India is making under an agreement with the British-Swedish MNC AstraZeneca...

Oxford and AstraZeneca are collaborating with partners across the world for a larger global programme made up of a phase-3 trial in the US...